0001104659-24-063003.txt : 20240517
0001104659-24-063003.hdr.sgml : 20240517
20240517161244
ACCESSION NUMBER: 0001104659-24-063003
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240503
FILED AS OF DATE: 20240517
DATE AS OF CHANGE: 20240517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pabon Daniel
CENTRAL INDEX KEY: 0001801407
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55450
FILM NUMBER: 24959803
MAIL ADDRESS:
STREET 1: 4880 HAVANA STREET, SUITE 201
CITY: DENVER
STATE: CO
ZIP: 80212
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medicine Man Technologies, Inc.
CENTRAL INDEX KEY: 0001622879
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
ORGANIZATION NAME: 07 Trade & Services
IRS NUMBER: 465289499
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 865 N. ALBION ST.
STREET 2: SUITE 300
CITY: DENVER
STATE: CO
ZIP: 80220
BUSINESS PHONE: 303-371-0387
MAIL ADDRESS:
STREET 1: 865 N. ALBION ST.
STREET 2: SUITE 300
CITY: DENVER
STATE: CO
ZIP: 80220
4/A
1
tm2414867-2_4aseq1.xml
OWNERSHIP DOCUMENT
X0508
4/A
2024-05-03
2024-05-07
0
0001622879
Medicine Man Technologies, Inc.
SHWZ
0001801407
Pabon Daniel
C/O MEDICINE MAN TECHNOLOGIES, INC.
865 N. ALBION ST., STE. 300
DENVER
CO
80220
0
1
0
0
See Remarks
0
Common Stock
2024-05-03
4
F
0
5166
0.62
D
10154
D
On May 7, 2024, the reporting person filed a Form 4 reporitng the shares issuable to such reporting person pursuant to the vesting of certain performance stock units ("PSU's"). Such Form 4 inadvertantly did not include the shares withheld to cover the tax withholding obligation in respect of vesting of the reporting person's PSUs. As reported in this amendment, 5,166 shares were withheld to cover the tax withholding obligation in respect of vesting of the reporting person's PSUs.
This Form 4 is being amended to report the number of PSU shares issued to the reporting person as the number was unknown at the time of original filing.
Chief Policy and Regulatory Affairs Officer
/s/ Daniel Pabon
2024-05-17